IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kynam Capital Management, LP

Q4 2022 Holdings

Filed 2023-02-14 | 31 holdings | $651.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Horizon Therapeutics PUB LSHSG46188101$125.2M1,100,00019.2%
Natera Inc(NTRA)COM632307104$104.6M2,603,20716.0%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$71.6M1,605,39011.0%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$65.2M2,561,18710.0%
Vaxcyte Inc(PCVX)COM92243G108$33.7M703,4415.2%
Viridian Therapeutics Inc(VRDN)COM92790C104$30.2M1,034,6974.6%
United Therapeutics Corp del(UTHR)COM91307C102$27.8M100,0004.3%
Vera Therapeutics Inc(VERA)CL A92337R101$27.3M1,409,0984.2%
Concert Pharmaceuticals Inc(CNCEEUR)COM206022105$25.8M4,420,3494.0%
GSK PLC(GSK)SPONSORED ADR37733W204$17.6M501,6432.7%
Burning Rock Biotech LTDSPONSORED ADS12233L107$16.6M7,391,5812.6%
Apellis Pharmaceuticals Inc(APLS)COM03753U106$15.5M300,0002.4%
Amarin Corp PLCSPONS ADR NEW023111206$11.7M9,642,2401.8%
Liquidia Corporation(LQDA)COM NEW53635D202$11.2M1,752,8411.7%
Cogent Biosciences Inc(COGT)COM19240Q201$9.2M794,0491.4%
Travere Therapeutics Inc(TVTX)COM89422G107$8.8M418,0991.3%
Wave Life Sciences LTD(WVE)SHSY95308105$8.7M1,238,1821.3%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$8.7M191,1581.3%
Protagonist Therapeutics Inc(PTGX)COM74366E102$5.7M520,9220.9%
Olema Pharmaceuticals Inc(OLMA)COM68062P106$5.0M2,025,2340.8%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$4.3M776,6620.7%
Gossamer BIO Inc(GOSS)COM38341P102$3.8M1,771,5450.6%
Sutro Biopharma IncCOM869367102$3.3M404,5440.5%
Allogene Therapeutics Inc(ALLO)COM019770106$2.5M396,3780.4%
Puma Biotechnology Inc(PBYI)COM74587V107$2.4M561,6090.4%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$2.3M733,9260.3%
Cabaletta BIO Inc(CABA)COM12674W109$1.5M165,4860.2%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$1.1M28,8870.2%
Connect Biopharma Hldgs LTDADS207523101$641.9K739,6490.1%
Neoleukin Therapeutics IncCOM64049K104$61.5K120,7640.0%
Catalyst Biosciences IncCOM NEW14888D208$47.7K90,4840.0%